US Lawmakers Question Health Insurance Execs on Rising Costs
In a heated congressional hearing, US lawmakers grilled executives from major health insurance companies, accusing them of driving up costs for consumers through monopolistic practices. The focus was on the rising premiums and healthcare expenses faced by millions of Americans, particularly those with Obamacare plans, following the end of special COVID-era tax credits.
CVS Health, Cigna, UnitedHealth, and Elevance executives were called to testify as the situation has left many families struggling to afford essential healthcare. The issue of industry integration, where companies control multiple aspects of the healthcare supply chain, was highlighted as a key factor in price hikes. For instance, CVS operates a health insurer, a pharmacy benefit manager, and a large retail pharmacy chain, giving it significant market power.
Congresswoman Lori Trahan, a Democrat, emphasized the negative impact of this concentration of power, stating that it weakens competition and forces families to pay more. UnitedHealth CEO Steve Hemsley, however, defended the company's mission to keep people healthy and affordable healthcare, acknowledging the need for transparency in rising healthcare costs.
The debate centered on the responsibility for the escalating costs. Republicans blamed the companies and the Affordable Care Act, while Democrats pointed to the failure to extend federal subsidies. Frank Pallone, a Democratic representative, criticized the Republican inaction on premium tax credits, leading to skyrocketing premiums for many.
KFF's survey revealed a 6% increase in annual premiums for US families with employer-sponsored health insurance in 2025, reaching nearly $27,000. Medical costs have been rising at a rate of over 7% annually, according to US government data. The affordability crisis is a significant concern in the upcoming congressional elections, with President Trump proposing direct payments to consumers instead of reinstating Obamacare subsidies.
UnitedHealth's written testimony revealed plans to offer rebates to Obamacare customers for 2026, but the effectiveness of such measures remains to be seen. The situation highlights the complex interplay between healthcare costs, insurance companies, and government policies, leaving many Americans concerned about their ability to access affordable healthcare.
